Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 2
1975 14
1976 27
1977 37
1978 68
1979 109
1980 143
1981 158
1982 131
1983 138
1984 156
1985 154
1986 118
1987 122
1988 145
1989 135
1990 112
1991 115
1992 105
1993 103
1994 86
1995 85
1996 106
1997 105
1998 113
1999 97
2000 108
2001 107
2002 120
2003 103
2004 110
2005 109
2006 123
2007 109
2008 144
2009 131
2010 125
2011 124
2012 146
2013 131
2014 136
2015 135
2016 134
2017 139
2018 142
2019 128
2020 168
2021 140
2022 124
2023 109
2024 104
2025 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,580 results

Results by year

Filters applied: . Clear all
Page 1
Travoprost/timolol.
Hoy SM, Keam SJ, Keating GM. Hoy SM, et al. Drugs Aging. 2006;23(7):587-97; discussion 598-9. doi: 10.2165/00002512-200623070-00005. Drugs Aging. 2006. PMID: 16930087 Review.
Both travoprost/timolol and latanoprost plus timolol maintained IOP control, and travoprost/timolol was shown to be noninferior to latanoprost/timolol in randomised, well designed studies. Travoprost/timolol was generally well tolerated, with a …
Both travoprost/timolol and latanoprost plus timolol maintained IOP control, and travoprost/timolol was shown to be non …
Timolol in the treatment of hard-to-heal wounds: a comprehensive review.
Cornwell D, Goldstein Z, Chrea B, McLafferty R. Cornwell D, et al. J Wound Care. 2024 Apr 2;33(4):243-252. doi: 10.12968/jowc.2024.33.4.243. J Wound Care. 2024. PMID: 38573903 Review.
OBJECTIVE: The aims of this study were to ascertain the effectiveness and safety of the off-label use of topical timolol as an adjunct treatment for hard-to-heal (chronic) wounds. Furthermore, to review and analyse the existing literature regarding the use of topical ti …
OBJECTIVE: The aims of this study were to ascertain the effectiveness and safety of the off-label use of topical timolol as an adjunc …
Timolol--further observations.
Zimmerman TJ, Canale P. Zimmerman TJ, et al. Ophthalmology. 1979 Jan;86(1):166-9. doi: 10.1016/s0161-6420(79)35537-3. Ophthalmology. 1979. PMID: 530562
Data from clinical records of patients using timolol confirm the ocular hypotensive effect of the drug in secondary glaucoma, aphakic glaucoma, ocular hypertension, and when used in combination with various other forms of glaucoma therapy. ...Although many adrenergic agent …
Data from clinical records of patients using timolol confirm the ocular hypotensive effect of the drug in secondary glaucoma, aphakic …
Timolol 0.5% ophthalmic solution influences cardiac function in healthy cats.
Tuleski GL, Pscheidt MJGR, Dos Santos JP, Sousa MG. Tuleski GL, et al. J Feline Med Surg. 2022 Jun;24(6):e57-e69. doi: 10.1177/1098612X221083372. Epub 2022 Apr 26. J Feline Med Surg. 2022. PMID: 35470745 Free PMC article.
METHODS: A total of 41 client-owned healthy cats underwent two echocardiograms 20 mins apart. The timolol group (33 cats) received a drop of timolol solution after the first examination. ...Regarding side effects, miosis occurred in 18 cats (54.5%). CONCLUSIONS AND …
METHODS: A total of 41 client-owned healthy cats underwent two echocardiograms 20 mins apart. The timolol group (33 cats) received a …
[Pharmacogenetics of timolol].
Moshetova LK, Soshina MM, Sychev DA, Turkina KI. Moshetova LK, et al. Vestn Oftalmol. 2019;135(3):137-143. doi: 10.17116/oftalma2019135031137. Vestn Oftalmol. 2019. PMID: 31393458 Russian.
The use of timolol maleate in clinical practice may be accompanied by severe side effects affecting different organs and systems. The fact that cells with beta-adrenergic receptors are widely common within the human body explains pharmacodynamic effects of timolol m …
The use of timolol maleate in clinical practice may be accompanied by severe side effects affecting different organs and systems. The …
Timolol maleate--a new glaucoma medication?
Zimmerman TJ. Zimmerman TJ. Invest Ophthalmol Vis Sci. 1977 Aug;16(8):687-8. Invest Ophthalmol Vis Sci. 1977. PMID: 407171 Clinical Trial. No abstract available.
Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma.
Heel RC, Brogden RN, Speight TM, Avery GS. Heel RC, et al. Drugs. 1979 Jan;17(1):38-55. doi: 10.2165/00003495-197917010-00002. Drugs. 1979. PMID: 369807 Review.
Timolol maleate is a nonselective beta-blocking drug used for the topical treatment of increased intraocular pressure in patients with chronic open angle glaucoma. ...Nevertheless, on the basis of present evidence, timolol appears to represent an important advance i …
Timolol maleate is a nonselective beta-blocking drug used for the topical treatment of increased intraocular pressure in patients wit …
Complete atrioventricular block due to timolol eye drops: a case report and literature review.
Wang Z, Denys I, Chen F, Cai L, Wang X, Kapusta DR, Lv Y, Gao J. Wang Z, et al. BMC Pharmacol Toxicol. 2019 Dec 2;20(1):73. doi: 10.1186/s40360-019-0370-2. BMC Pharmacol Toxicol. 2019. PMID: 31791399 Free PMC article. Review.
CONCLUSION: We conclude that chronic topical timolol administration may aggravate a cardiac conduction defect leading to an AV block that is only temporarily resolved by timolol cessation. Patients taking timolol should be routinely monitored for cardiovascul …
CONCLUSION: We conclude that chronic topical timolol administration may aggravate a cardiac conduction defect leading to an AV block …
Timolol maleate, a beta blocker eye drop, improved edema in a retinal vein occlusion model.
Fuma S, Hidaka Y, Nishinaka A, Yasuda H, Aoshima K, Nakamura S, Hara H, Shimazawa M. Fuma S, et al. Mol Vis. 2023 Oct 15;29:188-196. eCollection 2023. Mol Vis. 2023. PMID: 38222457 Free PMC article.
Primary human cultured retinal microvascular endothelial cells (HRMECs) were treated with timolol under hypoxic conditions, after which the gene expression pattern was investigated. ...CONCLUSIONS: These results indicate that timolol eye drops may be a potential opt …
Primary human cultured retinal microvascular endothelial cells (HRMECs) were treated with timolol under hypoxic conditions, after whi …
5,580 results